Inventor · disambiguated record
David Sourdive
Also filed as: SOURDIVE DAVID
7 granted patents·10 pending applications·68 citations·filing 2004–2025
80Inventor score
Top patents by PatentIndex Score
17 records- 0195US7842489B2Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereofCELLECTIS·Filed 2010·Granted Nov 30, 2010·63 cites·7 claims
- 0286US12252699B2Method for generating t-cells compatible for allogenic transplantationCELLECTIS·Filed 2023·Granted Mar 18, 2025·0 cites·12 claims
- 0381US10087453B2Modified diatoms for biofuel productionCELLECTIS·Filed 2014·Granted Oct 2, 2018·4 cites·20 claims
- 0475US2025277231A1Method for generating t-cells compatible for allogenic transplantationCELLECTIS·Filed 2025·Application pending·0 cites
- 0572US2025034641A1Cellular immunotherapy for repetitive administrationCELLECTIS·Filed 2024·Application pending·0 cites
- 0671US11820996B2Method for generating T-cells compatible for allogenic transplantationCELLECTIS·Filed 2018·Granted Nov 21, 2023·0 cites·14 claims
- 0763US10357515B2Method for generating batches of allogeneic T-cells with averaged potencyCELLECTIS·Filed 2014·Granted Jul 23, 2019·1 cites·20 claims
- 0858US12144825B2Cellular immunotherapy for repetitive administrationCELLECTIS·Filed 2018·Granted Nov 19, 2024·0 cites·20 claims
- 0958US2011151539A1Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereofARNOULD SYLVAIN·Filed 2011·Application pending·0 cites
- 1057US2012159659A1Custom-made meganuclease and use thereofARNOULD SYLVAIN·Filed 2010·Application pending·0 cites
- 1157US2006153826A1Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereofARNOULD SYLVAIN·Filed 2004·Application pending·0 cites
- 1253US10813951B2Method of engineering chemotherapy drug resistant T-cells for immunotherapyCELLECTIS·Filed 2014·Granted Oct 27, 2020·0 cites·17 claims
- 1350US2017016025A1Method for generating t-cells compatible for allogenic transplantationCELLECTIS·Filed 2015·Application pending·0 cites
- 1448US2021268028A1Chimeric antigen receptors (car)-expressing cells and combination treatment for immunotherapy of patients with relapse refractory adverse genetic risk amlCELLECTIS·Filed 2019·Application pending·0 cites
- 1546US2015353885A1Method to counter-select cells or organisms by linking loci to nuclease componentsCELLECTIS·Filed 2014·Application pending·0 cites
- 1637US2013164850A1Method for targeted genomic events in algaeSOURDIVE DAVID·Filed 2011·Application pending·0 cites
- 1737US2013189759A1Meganucleases variants cleaving a dna target sequence in the nanog gene and uses thereofSOURDIVE DAVID·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Sourdive files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →